本页面由Tiger Trade Technology Pte. Ltd.提供服务

Belite Bio, Inc.

158.59
+4.102.65%
盘后:158.590.00000.00%19:30 EDT
成交量:25.92万
成交额:4,110.28万
市值:63.87亿
市盈率:-57.92
高:160.74
开:154.95
低:154.63
收:154.49
52周最高:200.00
52周最低:77.64
股本:4,027.21万
流通股本:1,955.07万
量比:1.72
换手率:1.33%
股息:- -
股息率:- -
每股收益(TTM):-2.7382
每股收益(LYR):-2.3141
净资产收益率:-22.10%
总资产收益率:-15.65%
市净率:8.22
市盈率(LYR):-68.53

数据加载中...

2024/03/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/25

SEC问询函

Form CORRESP - Correspondence
2023/05/05

SEC问询函

Form CORRESP - Correspondence
2023/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/07/08

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/04/27

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers